Figure 4: Schematic diagram of the HIV infection cycle and the predicted outcome of ... number of diseases and have improved the quality of life, they still cover only a small portion of the ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

HIV infections are lifelong and can weaken the immune system, causing a patient to be more susceptible to infection and ...

Mizoram is currently grappling with a rise in the prevalence of Human immunodeficiency virus (HIV). Reportedly, the North-Eastern state is has reported the highest HIV prevalence rate in India at ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term protection. If this yearly injection is approved and widely implemented ...

The latest episode of The Top Line, sponsored by ViiV Healthcare, features Dr. Luis Buzón, an infectious disease specialist, discussing the critical role of real-world evidence in HIV treatment ...

But the other piece of it is, I ask clinicians to make sure that they share stories like mine; to let their patients know, even if you have HIV, you can live a long and full life. Even if you have ...

It was sent to 2,500 patients who had potentially been exposed to bloodborne viruses including HIV, hepatitis B, and hepatitis C due to what the agency described as a failure to properly clean ...

Staffers at a Christian maternity clinic in Côte d’Ivoire are watching HIV drugs rapidly disappear ... They’ve been told every month their whole life, ‘If you don’t take [the medicine ...

Mary Hall is a editor for Investopedia's Advisor Insights, in addition to being the editor of several books and doctoral papers. Mary received her bachelor's in English from Kent State University ...